Samik Pharm Co Ltd
KOSDAQ:014950
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Samik Pharm Co Ltd
KOSDAQ:014950
|
KR |
|
Cullman Bancorp, Inc.
OTC:CULL
|
US |
|
C
|
Cordoba Minerals Corp
OTC:CDBMF
|
CA |
|
F
|
Foremost Clean Energy Ltd
CNSX:FAT
|
CA |
|
A
|
AGFA Gevaert NV
SWB:AGE
|
BE |
|
I
|
Ion Electronic Materials Co Ltd
TPEX:6959
|
TW |
|
R
|
RTG Mining Inc
ASX:RTG
|
AU |
|
S
|
Sunway Construction Group Bhd
KLSE:SUNCON
|
MY |
|
Trigano SA
F:TGO
|
FR |
|
Exagen Inc
NASDAQ:XGN
|
US |
|
ATHA Energy Corp
F:X5U
|
CA |
|
C
|
Cantor Equity Partners Vi, Inc
NASDAQ:CEPS
|
US |
|
D
|
Dadex Eternit Ltd
KAR:DADX
|
PK |
|
N
|
Nirvana Daii PCL
SET:NVD
|
TH |
Bankruptcy Probability
Samik Pharm Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Samik Pharm Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
S
|
Samik Pharm Co Ltd
KOSDAQ:014950
|
78B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
622.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
479.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
352.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
346.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
228.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
184.4B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
336.3B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
182.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Samik Pharm Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Samik Pharm Co Ltd has total debt of 190.6m KRW. This includes both short-term (0 KRW) and long-term (190.6m KRW) debt.
You can find a full breakdown on its Balance Sheet.